natgillin/translations-raw huggingface dataset:
Pharmacotherapeutic group: Anti-anaemic preparations, other antianemic preparations, ATC Code: B03XA02.
Farmakoterapeutisk grupp: Medel vid anemier, övriga medel vid anemier, ATC-kod: B03XA02.
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16 The active substance, pregabalin, is a gamma-aminobutyric acid analogue
Farmakoterapeutisk grupp: Antiepileptika, övriga antiepileptika ATC kod: N03AX16 Den aktiva substansen pregabalin är en gamma-aminosmörsyra-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16 The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-
Farmakoterapeutisk grupp: Antiepileptika, övriga antiepileptika ATC kod: N03AX16 Den aktiva substansen pregabalin är en gamma-aminosmörsyra-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics; ATC code: N03AX16.
Farmakoterapeutisk grupp: Antiepileptika, övriga antiepileptika; ATC kod: N03AX16
Pharmacotherapeutic group: Anti-estrogens, ATC code: L02BA02
Farmakoterapeutisk grupp: Antiöstrogener, ATC-kod: L02BA02.
Pharmacotherapeutic group: anti-infectious, ATC code: J07BC01
Farmakoterapeutisk grupp :vaccin mot Hepatit B, ytantigenvaccin, ATC - kod: J07BC01
Pharmacotherapeutic group: anti-infectious, ATC code: J07BC01
Farmakoterapeutisk grupp: vaccin mot Hepatit B, ytantigenvaccin, ATC - kod: J07BC01
Pharmacotherapeutic group: anti-infectious, ATC code: J07BC01
Farmakoterapeutisk grupp:vaccin mot Hepatit B, ytantigenvaccin, ATC - kod: J07BC01
Pharmacotherapeutic Group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams).
Farmakoterapeutisk grupp: Anti-inflammatoriska och anti-reumatiska produkter, icke-steroider (oxicamer)
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams).
Farmakoterapeutisk grupp: Antiinflammatoriska och antireumatiska medel, icke-steroida (oxikamer)
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids, coxibs.
Farmakoterapeutisk grupp: Icke-steroida antiinflammatoriska/antireumatiska medel, coxiber.
Pharmacotherapeutic group: Anti-Parkinson drugs, dopaminergic agents, ATC code: N04BA02 Mechanism of action
Farmakoterapeutisk grupp: Medel vid parkinsonism, dopaminerga medel, ATC-kod: N04BA02 Verkningsmekanism
Pharmacotherapeutic group: Anti-Parkinson-Drugs, Monoamine oxidase -B inhibitors, ATC code: N04BD02
Farmakoterapeutisk grupp: Medel mot Parkinsons sjukdom, Monoaminoxidas-B hämmare ATC-kod N04BD02.
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA..
Farmakoterapeutisk grupp: Medel vid anemier, ATC-kod: B03XA.
Pharmacotherapeutic group: antianemic, ATC code: B03XA01 Mechanism of action
Farmakoterapeutisk grupp: medel vid anemier, ATC-kod: B03XA01
Pharmacotherapeutic group: antianemic, ATC code: B03XA01 Mechanism of action
Farmakoterapeutisk grupp: medel vid anemier, ATC-kod: B03XA01 Verkningsmekanism
Pharmacotherapeutic group: antibacterial quinolone ATCvet code: QJ 01 MA
Farmakoterapeutisk grupp: Antibakteriella kinolonderivat ATCvet kod: QJ01M A96
Pharmacotherapeutic group: Antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA03
Farmakoterapeutisk grupp: Antibakteriella medel för systemiskt bruk, antibakteriella glykopeptider, ATC-kod: J01XA03
Pharmacotherapeutic group: antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA04.
Farmakoterapeutisk grupp: antibakteriella medel för systemiskt bruk, glykopeptidantibiotika, ATC- kod: J01XA04.
Pharmacotherapeutic group: Antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA05
Farmakoterapeutisk grupp: Antibakteriella medel för systemiskt bruk, glykopeptidantibiotika, ATC- kod: J01XA05
Pharmacotherapeutic group: antibacterials for systemic use, macrolides, lincosamides and streptogramins, ATC Code: J01FA15.
Farmakoterapeutisk grupp: antibakteriella medel för systemiskt bruk, makrolider, linkosamider och streptograminer, ATC-kod: J01FA15.
Pharmacotherapeutic group: Antibacterials for systemic use, other cephalosporins, ATC code: J01DI02
Farmakoterapeutisk grupp: antibakteriella medel för systemiskt bruk, övriga cefalosporiner, ATC-kod: J01DI02
Pharmacotherapeutic group: Antibacterials for systemic use, third-generation cephalosporins.
Farmakoterapeutisk grupp: Antibakteriella medel för systemiskt bruk, cefalosporiner, tredje generationen.
Pharmacotherapeutic group: Antibiotics and chemotherapeutics for dermatological use, Antibiotics for topical use.
Farmakoterapeutisk grupp: Antibiotika och kemoterapeutika för dermatologiskt bruk, Antibiotika för topikal användning.
Pharmacotherapeutic group: Anticholinergics; ATC Code: R03BB05.
Farmakoterapeutisk grupp: Antikolinergika, ATC-kod: R03BB05.
Pharmacotherapeutic group: anticholinesterases, ATC code: N06D A03
Farmakoterapeutisk grupp: Kolinesterashämmare, ATC-kod: N06DA03.
Pharmacotherapeutic group: Antidotes, ATC code: V03AB33 Mechanism of action
Farmakoterapeutisk grupp: Medel vid förgiftningar, ATC-kod: V03AB33 Verkningsmekanism
Pharmacotherapeutic group: Antiemetics and antinauseants, ATC code: A04AD12
Farmakoterapeutisk grupp: Antiemetika, ATC-kod A04AD12.
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists ATC code: A04AA02
Farmakoterapeutisk grupp: Antiemetika och medel mot illamående, serotonin (5HT3)-antagonister ATC-kod: A04AA02
Pharmacotherapeutic group: Antiepileptics Other antiepileptics imepitoin ATCvet code: QN03AX90
Farmakoterapeutisk grupp: Antiepileptika/andra antiepileptika/imepitoin ATCvet-kod: QN03AX90
Pharmacotherapeutic group: Antiepileptics, carboxamide derivatives, ATC code: N03AF04 Mechanism of action
Farmakoterapeutisk grupp: Antiepileptika, karboxamidderivat, ATC-kod: N03AF04 Verkningsmekanism
Pharmacotherapeutic group: Antiepileptics, other antiepileptics, ATC code: N03AX17 Mechanism of action
Farmakoterapeutisk grupp: antiepileptika, övriga antiepileptika, ATC-kod: N03AX17 Verkningsmekanism
Pharmacotherapeutic group: Antiepileptics, other antiepileptics, ATC code: N03AX17 Mechanism of action
Farmakoterapeutisk grupp: antiepileptiska, övriga antiepileptika, ATC-kod: N03AX17 Verkningsmekanism
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX18 Mechanism of action
Farmakoterapeutisk grupp: Antiepileptika, övriga antiepileptika, ATC-kod N03AX18 Verkningsmekanism
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX23 Mechanism of action
Farmakoterapeutisk grupp: antiepileptika, övriga antiepileptika, ATC-kod: N03AX23 Verkningsmekanism
Pharmacotherapeutic Group: Antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, ATC code: S01EC04
Farmakoterapeutisk grupp: Medel vid glaukom och miotika, karbanhydrashämmare, ATC-kod: S01EC04.
Pharmacotherapeutic group: Antihaemorrhagic, blood coagulation factor IX; ATC code: B02BD09 Mechanism of action
Farmakoterapeutisk grupp: Antihemofili koagulationsfaktor IX, ATC-kod B02BD09 Verkningsmekanism
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor IX, ATC code: B02BD04 Mechanism of action
Farmakoterapeutisk grupp: hemostatika, koagulationsfaktor IX, ATC-kod: B02BD04 Verkningsmekanism
Pharmacotherapeutic Group: antihaemorrhagics, blood coagulation factor IX.
Farmakoterapeutisk grupp: antihemorragisk, blodkoagulationsfaktor IX.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapeutisk grupp: hemostatika, koagulationsfaktor VIII, ATC-kod: B02BD02 Verkningsmekanism
Pharmacotherapeutic group: Antihaemorrhagics, other systemic hemostatics, ATC code: B02BX04 Mechanism of action
Farmakoterapeutisk grupp: Hemostatika, övriga hemostatika för systemiskt bruk, ATC-kod B02BX04 Verkningsmekanism
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factors, von Willebrand factor and coagulation factor VIII in combination.
Farmakoterapeutisk grupp: Hemostatika: blodkoagulationsfaktorer, von Willebrand faktor och koagulationsfaktor VIII i kombination.
Pharmacotherapeutic group: antihemorrhagics, blood coagulation factor VIII, ATC code: not yet assigned.
Farmakoterapeutisk grupp: hemostatika, koagulationsfaktor VIII, ATC-kod: B02BD02.
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapeutisk grupp: hemostatika blodkoagulationsfaktor VIII, ATC-kod: B02BD02 Verkningsmekanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutisk grupp: antihistamin - H1 antagonist; ATC-kod: R06A X27 Verkningsmekanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutisk grupp: antihistamin - H1 antagonist; ATC-kod: R06AX27 Verkningsmekanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutisk grupp: antihistamin – H1 antagonist; ATC-kod: R06A X27 Verkningsmekanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutisk grupp: antihistamin – H1 antagonist; ATC-kod: R06AX27 Verkningsmekanism
Pharmacotherapeutic group: Antihypertensives for pulmonary arterial hypertension, ATC code: C02KX05
Farmakoterapeutisk grupp: Övriga antihypertensiva medel ATC-kod: C02KX05
Pharmacotherapeutic group: Antihypertensives, antiadrenergic agents, centrally acting ATC code: C02AC02.
Farmakoterapeutisk grupp: antihypertensiva medel, antiadrenerga preparat med central verkan, ATC- kod: C02AC02.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATC vet code: QM01AC06
Farmakoterapeutisk grupp: Icke-steroida antiinflammatoriska och antireumatiska medel (oxikamer) ATCvet-kod: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapeutisk grup: Icke-steroida antiinflammatoriska/antireumatiska medel (oxikamer) ATCvet-kod: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapeutisk grupp: antiinflammatoriska och antireumatiska medel, icke-steroida ATCvet-kod: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet Code: QM01AC06
Farmakoterapeutisk grupp: Antiinflammatoriska och antireumatiska medel, icke-steroider (oxikamer)
Pharmacotherapeutic group: Antimetabolites, pyrimidine analogues, ATC code: L01BC01 Mechanism of action
Farmakoterapeutisk grupp: Antimetaboliter (pyrimidinanaloger) ATC-kod L01BC01 Verkningsmekanism
Pharmacotherapeutic group: antimycotics for systemic use, ATC code: J02AX04 Mechanism of action
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk, ATC-kod: J02AX04 Verkningsmekanism
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C03 Mode of Action
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk – triazolderivat, ATC-kod: J02A C03 Verkningsmekanism
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C03 Mode of Action
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk – triazolderivat, ATC-kod: J02A C03 Verkningsmekanism:
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C04.
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk, triazolderivat, ATC-kod: J02AC04.
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02AC05 Mechanism of action
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk, triazolderivat, ATC-kod: J02AC05 Verkningsmekanism
Pharmacotherapeutic group: Antimycotics for systemic use, – triazole derivatives ATC code: J02AC03 Mode of action
Farmakoterapeutisk grupp: Antimykotika för systemiskt bruk – triazolderivat, ATC-kod: J02AC03 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agent protein kinase inhibitor, ATC code: L01XE03 Mechanism of action
Farmakoterapeutisk grupp: antineoplastiska medel, proteinkinashämmare, ATC-kod: L01XE03 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agent, folic acid analogues, ATC code: L01BA04
Farmakoterapeutisk grupp: Folsyraanaloger, ATC-kod: L01BA04
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, monoclonal antibodies, ATC code: L01XC14
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, övriga cytostatiska/cytotoxiska medel, monoklonala antikroppar, ATC-kod: L01XC14
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, protein kinase inhibitor, ATC code: L01XE07
Farmakoterapeutisk grupp: Alkylerande medel, övriga cytostatiska/cytotoxiska medel, proteinkinashämmare, ATC-kod: L01XE07
Pharmacotherapeutic group: antineoplastic agent, protein kinase inhibitor, ATC code: L01XE26.
Farmakoterapeutisk grupp: cytostatikum, proteinkinashämmare, ATC-kod: L01XE26
Pharmacotherapeutic group: Antineoplastic agent, Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD04
Farmakoterapeutisk grupp: cytostatiska/cytotoxiska medel, sensibiliserande ämnen för strålning/fotodynamisk behandling, ATC-kod: L01XD04
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01A X03 Mechanism of action
Farmakoterapeutisk grupp: Övriga alkylerande medel, ATC-kod L01A X03 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapeutisk grupp: Cytostatika/cytotoxiska medel, Akylerande medel, ATC-kod: L01AC01 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, ATC code: L01BC59 Mechanism of action
Farmakoterapeutisk grupp: cytostatiska/cytotoxiska medel, antimetaboliter, ATC-kod: L01BC59 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues.
Farmakoterapeutisk grupp: Antineoplastiska medel, antimetaboliter, folsyraanaloger.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, purine analogues, ATC code: L01B B 07
Farmakoterapeutisk grupp: Antineoplastiska medel, antimetaboliter, purinanaloger, ATC- kod L01B B 07
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, pyrimidine analogues; ATC Code: L01BC08
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, antimetaboliter, pyrimidinanaloger, ATC-kod: L01BC08
Pharmacotherapeutic group: Antineoplastic agents, ATC code: L01XE38 Mechanism of action
Farmakoterapeutisk grupp: Antineoplastiska medel, ATC-kod: L01XE38 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agents, folic acid analogues, ATC code: L01BA04
Farmakoterapeutisk grupp: Antineoplastiska medel, folsyraanaloger, ATC-kod L01BA04
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC04.
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, monoklonala antikroppar, ATC kod: L01XC04.
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC06 Mechanism of action
Farmakoterapeutisk grupp: Antineoplastiska medel, monoklonala antikroppar, ATC-kod L01XC06 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC11.
Farmakoterapeutisk grupp: antineoplastiska medel, monoklonala antikroppar ATC-kod: L01XC11.
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC13 Mechanism of action
Farmakoterapeutisk grupp: Antineoplastiska medel, monoklonala antikroppar, ATC-kod: L01XC13 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agents, monoclonal antibodies, ATC code: L01XC16 Mechanism of action
Farmakoterapeutisk grupp: cytostatiska/cytotoxiska medel, monoklonala antikroppar, ATC-kod: L01XC16 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies.
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, monoklonala antikroppar ATC-kod: L01XC18
Pharmacotherapeutic group: antineoplastic agents, other antineoplastic agents, ATC code: L01XX47
Farmakoterapeutisk grupp: cytostatiska/cytotoxiska medel, övriga cytostatiska/cytotoxiska medel, ATC-kod: L01XX47
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, protein- kinase inhibitors, ATC code: L01XE11
Farmakoterapeutisk grupp: Antineoplastiska medel, övriga antineoplastiska medel, proteinkinashämmare, ATC-kod: L01XE11
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapeutisk grupp: antineoplastiska medel, växtalkaloider och andra naturprodukter, taxaner, ATC-kod: L01CD02
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk grupp: antineoplastiskt medel, protein-kinashämmare, ATC-kod: L01XE01 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk grupp: Cytostatiska medel, proteinkinashämmare, ATC-kod: L01XE01 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE15 Mechanism of action and pharmacodynamic effects
Farmakoterapeutisk grupp: Antineoplastiskt medel, proteinkinashämmare, ATC-kod: L01XE15 Verkningsmekanism och farmakodynamisk effekt
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors, ATC code: L01XE06
Farmakoterapeutisk grupp: Övriga cytostatiska/cytotoxiska medel, proteinkinashämmare, ATC-kod: L01XE06
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE18 Mechanism of action
Farmakoterapeutisk grupp: Antineoplastiska medel, proteinkinashämmare, ATC-kod: L01XE18 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE27.
Farmakoterapeutisk grupp: cytostatiska/cytotoxiska medel, proteinkinashämmare, ATC-kod: L01XE27.
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE31 Mechanism of action
Farmakoterapeutisk grupp: Cytotoxiska medel, proteinkinashämmare, ATC-kod L01XE31 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors.
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, proteinkinashämmare.
Pharmacotherapeutic group: Antineoplastic Agents, Taxanes, ATC Code: L01CD 02 Mechanism of action
Farmakoterapeutisk grupp: Cytostatiska/cytotoxiska medel, Taxaner, ATC-kod: L01CD 02 Verkningsmekanism
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutisk grupp: cytostatika, taxaner, ATC-kod: L01CD02 Verkningsmekanism
Pharmacotherapeutic group: Antineoplastic agents-other alkylating agents, ATC code: L01A X03 Mechanism of action
Farmakoterapeutisk grupp: Cytotoxiska medel, övriga alkylerande medel, ATC-kod: L01A X03 Verkningsmekanism
Pharmacotherapeutic group: antiparasitic product, other anthelmintic agents.
Farmakoterapeutisk grupp: antiparasitära medel, andra anthelmintikum.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents – endectocides.
Farmakoterapeutisk grupp: Antiparasitiska produkter, insekticider och insektsmedel – endektocider.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, other ectoparasiticides for topical use, pyriproxyfen, combinations.
Farmakoterapeutisk grupp: Medel mot ektoparasiter, insektsdödande och repellerande medel, övriga medel mot ektoparasiter för utvärtes bruk, pyriproxyfen, kombinationer.
Pharmacotherapeutic group: Antiprotozoals, antimalarials, artemisinin and derivatives, combinations, ATC code: P01BF05.
Farmakoterapeutisk grupp: Medel mot protozoer, malariamedel, artemisinin och derivat, kombinationer, ATC-kod: P01BF05
Pharmacotherapeutic group: Antithrombotic agent - direct thrombin inhibitor, ATC Code: B01AE02
Farmakoterapeutisk grupp: Antikoagulantia – direkta trombinhämmare, ATC-kod: B01AE02
Pharmacotherapeutic group: Antithrombotic agent – direct thrombin inhibitor, ATC Code: B01AE02
Farmakoterapeutisk grupp: Antikoagulantia – direkta trombinhämmare, ATC-kod: B01AE02
Pharmacotherapeutic group: Antithrombotic agents, direct factor Xa inhibitors, ATC code: B01AF02 Mechanism of action
Farmakoterapeutisk grupp: Antitrombotiska medel, direkt faktor Xa-hämmare, ATC-kod: B01AF02 Verkningsmekanism
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC code: B01AC-04.
Farmakoterapeutisk grupp: Antikoagulantia, trombocytaggregationshämmande medel exklusive heparin, ATC-kod: B01A C04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutisk grupp: Antikoagulantia, trombocytaggregationshämmande medel exklusive heparin, ATC-kod: B01AC04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutisk grupp: antitrombotiska medel, trombocytaggregationshämmande medel exklusive heparin, ATC-kod: B01AC-04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC04.
Farmakoterapeutisk grupp: Antitrombotiskt medel, trombocytaggregationshämmande medel exklusive heparin, ATC-kod: B01AC04.
Pharmacotherapeutic group: Antiviral for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR19
Farmakoterapeutisk grupp: Antivirala medel för systemiskt bruk; antivirala medel mot HIV-infektioner, kombinationer, ATC-kod: J05AR19
Pharmacotherapeutic group: Antivirals for systemic use, neuraminidase inhibitors ATC code: J05AH02
Farmakoterapeutisk grupp: Virushämmande medel för systemiskt bruk, neuraminidashämmare ATC- kod: J05AH02
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Farmakoterapeutisk grupp: Antivirala för systemiskt bruk, icke nukleosidanalog omvänd transkriptashämmare, ATC-kod: J05A G01.
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Farmakoterapeutisk grupp: Virushämmande medel för systemiskt bruk, (Icke nukleosidanalog, omvänd transkriptashämmare), ATC-kod: J05A G01.
Pharmacotherapeutic group: Antivirals for systemic use, nucleosides and nucleotides excluding reverse transcriptase inhibitors, ATC code: J05AB12
Farmakoterapeutisk grupp: Antivirusmedel för systemiskt bruk, nukleosider och nukleotider exkl. omvänd-transkriptas-hämmare, ATC-kod J05AB12
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE08
Farmakoterapeutisk grupp: antivirala medel för systemiskt bruk, proteashämmare, ATC-kod: J05A E08
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE08 Mechanism of action
Farmakoterapeutisk grupp: antivirala medel för systemiskt bruk, proteashämmare, ATC-kod: J05AE08 Verkningsmekanism
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE12
Farmakoterapeutisk grupp: virushämmande medel för systemiskt bruk, proteashämmare, ATC-kod: J05AE12
Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR16
Farmakoterapeutisk grupp: Virushämmande medel mot hiv-infektioner, kombinationer, ATC-kod: J05AR16.
Pharmacotherapeutic group: Antivirals for systemic use; Direct-acting antiviral, ATC code: J05AX68
Farmakoterapeutisk grupp: Virushämmande medel för systemiskt bruk, direkt verkande, ATC-kod: J05AX68.
Pharmacotherapeutic group: ATC code: D03BA03 bromelains
Farmakoterapeutisk grupp: ATC-kod: D03BA03 bromelains
Pharmacotherapeutic group: Bacterial vaccines, ATC-code: J07AE01 Mechanism of action
Farmakoterapeutisk grupp: Bakteriella vacciner, ATC-kod: J07AE01 Verkningsmekanism
Pharmacotherapeutic group: Beta-Blocking agent, non-selective, ATC code: C07AA05 Mechanism of action
Farmakoterapeutisk grupp: Beta-receptorblockerare, icke-selektiva, ATC-kod: C07AA05 Verkningsmekanism